Krystal Biotech Inc (KRYS) — Cash Flow Reinvestment Rate
Krystal Biotech Inc (KRYS) has a Cash Flow Reinvestment Rate of 2.16x as of June 2026, reinvesting $161.58 Million (capex $3.56 Million plus investments $-158.02 Million) from operating cash flow of $74.79 Million. See KRYS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Krystal Biotech Inc Cash Flow Reinvestment Rate (2024–2025)
Historical reinvestment intensity for Krystal Biotech Inc across 2 annual periods. For the full cash flow conversion analysis, see Krystal Biotech Inc cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Krystal Biotech Inc (2024–2025)
Year-by-year capital reinvestment analysis for Krystal Biotech Inc. See financial flexibility index of Krystal Biotech Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | $58.85 Million | $200.87 Million | $11.95 Million | ▼ -78.4% |
| 2024 | 1.36x | $167.68 Million | $123.42 Million | $4.24 Million | — |